April 24, 2018 / 12:14 PM / 4 months ago

BRIEF-Tetra Bio-Pharma Signs Landmark Commercialization Term Sheet For Its Product PPP001 In Israel

April 24 (Reuters) - Tetra Bio Pharma Inc:

* TETRA BIO-PHARMA SIGNS LANDMARK COMMERCIALIZATION TERM SHEET FOR ITS LEAD PHARMACEUTICAL PRODUCT, PPP001, IN ISRAEL

* TETRA BIO PHARMA - SIGNED BINDING TERM SHEET FOR MARKETING & DISTRIBUTION OF PPP001 IN ISRAEL WITH KAMADA LTD

* TETRA BIO PHARMA INC - UNDER AGREEMENT TERMS, KAMADA WILL BE RESPONSIBLE FOR REGISTERING PRODUCT, MARKETING & DISTRIBUTION, IN ISRAEL

* TETRA BIO PHARMA - CO TO BE ELIGIBLE TO RECEIVE CERTAIN MILESTONE PAYMENTS, UNDISCLOSED PERCENTAGE OF SALES OF PPP001 GENERATED BY KAMADA IN ISRAEL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below